Todd Jude Yancey
Member of Advisory Board & Chief Strategic AdvisorDr. Todd Jude Yancey, M.D. serves as Member of Advisory Board for Agenus Inc. since 2023 and its Chief Strategic Advisor since November 2023. He served as Vice President of Clinical Development at Onyx Pharmaceuticals, Inc. since January 2009. Dr. Yancey served as a Senior Vice President of New Market Development at BeiGene, Ltd. and served as its Senior Vice President of Global Medical Affairs until 2021. Dr. Yancey served as Vice President, Medical Affairs and Program Leadership and Vice President, Medical Affairs since joining Onyx in August 2006. Prior to Onyx, Dr. Yancey served as a Medical Director at Genentech. His group provided medical oversight for the Tarceva drug development program and product life-cycle management. In this role, he oversaw the Investigator Sponsored Trial program, provided Medical Science Liaison and commercial support, and managed scientific education initiatives. He served as the Senior Vice President of Medical and Scientific Affairs at BESTMED, the medical communications arm of Saatchi and Saatchi. From 2002 to 2005, Dr. Yancey served at Amgen in both the U.S. and European Oncology organizations and also served as Director and Team Leader, Inflammation Regional Medical Liaisons. Dr. Yancey earned his M.D. and B.A. at the University of Virginia and completed his residency and fellowship training at The New York Hospital-Cornell University Medical College.
Positions
- Company NameAgenus Inc.Stock CodeAGENPositionMember of Advisory Board & Chief Strategic AdvisorColleagues
- GHGaro H. ArmenFounder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman
- SJSteven J. O’DayChief Medical Officer
- JSJennifer S. BuellDirector and President & CEO of MiNK Therapeutics
- CWCraig WinterChief Information Officer
- ZAZack ArmenVice President of Investor Relations & Corporate Development
- BJBrian J. CorveseIndependent Director
- TLThomas L. HarrisonIndependent Director
